Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)
Germany flag Germany · Delayed Price · Currency is EUR
2.312
+0.024 (1.05%)
At close: Dec 4, 2025

Shanghai Fosun Pharmaceutical (Group) Company Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally.

The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride.

It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases.

In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services.

Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Country China
Founded 1994
Industry Pharmaceutical Preparations
Employees 40,557
CEO Yi Liu

Contact Details

Address:
Building A
Shanghai, 200233
China
Phone 86 21 3398 7000
Website fosunpharma.com

Stock Details

Ticker Symbol 08HH
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 2834

Key Executives

Name Position
Yi Liu Chief Executive Officer